Scientific Committee

  • Alexander Baldacchino (Professor of Medicine, Psychiatry and Addictions, University of St Andrews, UK)
  • Amy Peacock (National Drug and Alcohol Research Centre, University of New South Wales Sydney, Sydney, Australia)
  • Andrew Bennett (Independent Public Health Practitioner, UK)
  • Angela Me (Chief of the Research and Trend Analysis Branch, United Nations Office on Drugs and Crime, Austria)
  • Angelina Brotherhood (Health Expert, Austrian National Public Health Institute - Gesundheit Österreich GmbH, GÖG, Austria)
  • Anne Line Bretteville-Jensen (Research Director, Norwegian Institute for Alcohol and Drug Research (SIRUS), Norway)
  • Anne Lingford-Hughes (Professor of Addiction Biology at Imperial College and Head, Centre for Psychiatry, UK)
  • Antoni Gual (Director of the Addictions Unit, Hospital Clínic Barcelona, Spain)
  • Beau Kilmer (Co-director and senior policy researcher, RAND Drug Policy Research Center; Professor, Pardee RAND Graduate School, USA)
  • Bronwyn Myers-Franchi (Professor, Curtin enAble Institute, Faculty of Health Sciences, Curtin University, Perth, Australia)
  • Catherine Comiskey (Head of School of Nursing and Midwifery, Trinity College, Ireland)
  • Charlotte Colman (Professor Drug Policy and Criminology (Department of Criminology, Criminal Law & Social Law, Ghent University, Belgium)
  • Charlotte de Kock (Institute for Social Drug Research, Ghent University, Belgium)
  • Charlie Lloyd (Professor of Criminal Justice and Social Policy, University of York, UK)
  • Chris Wilkins (Senior Researcher, Drugs Team Leader, SHORE & Whariki Research Centre, College of Health, Massey University, Auckland, New Zealand)
  • Cuneyt Evren (Professor of Psychiatry, Member of Scientific Committee of Green Crescent, Istanbul, Türkiye)
  • Dirk Korf (Professor, Bonger Institute of Criminology, University of Amsterdam, Netherlands)
  • Eilish Gilvarry (President of the Society for the Study of Addiction, Honorary Professor of Addiction Psychiatry, Newcastle University, UK)
  • Emanuele Scafato (Research's Director, Director of the National Observatory on Alcohol, Head of Italian Monitoring System on Alcohol/National Surveillance System SISMA, National Centre on Addictions and Doping, Istituto Superiore di Sanità, Roma, Italy)
  • Fabrizio Faggiano (Professor of Public Health at the Department of Translational Medicine of the University of the Piemonte Orientale, Italy)
  • Felix Carvalho (Presidente do Conselho Científico, Faculdade de Farmácia da Universidade do Porto, Portugal)
  • Fernando Rodríguez de Fonseca (Fundación IMABIS, Hosp. Univ. Carlos Haya de Málaga, Spain)
  • Gabriele Fischer (Medical Director of the Addiction Clinic at the Medical University Vienna, Austria)
  • Gerhard Bühringer (Chair of Addiction Research, Institute for Clinical Psychology and Psychotherapy, Technische Universität Dresden, Germany)
  • Graça Vilar (Director of the Planning and Intervention Department of SICAD, Master in forensic medicine and forensic sciences, Graduate Assistant of Psychiatry Hospital, Portugal)
  • Håkan Leifman (Director, Swedish Council for Information on Alcohol and Other Drugs (CAN), Sweden)
  • Harry Sumnall (Professor, Centre for Public Health, Liverpool John Moores University, UK)
  • Henk Garretsen (Professor, Director Tranzo, Scientific Centre for Care and Welfare, Tilburg University, Netherlands)
  • Henri Bergeron (Chair in Health Studies, Sciences Po Paris, France)
  • Henrique Lopes (Director of the Nova Center for Global Health, Universidade Nova de Lisboa, Vice-president for Health and development of the World Committee for Longlife Learning, UNESCO and WHO expert)
  • Ilkka Ojanperä (Professor of Forensic Toxicology, Department of Forensic Medicine, University of Helsinki; and Finnish Institute for Health and Welfare, Helsinki, Finland)
  • Janusz Sieroslawski (Institute of Psychiatry and Neurology, Poland)
  • Jason Grebely (Associate Professor, The Kirby Institute, UNSW Sydney, Australia)
  • Jo-Hanna Ivers (School of Medicine, Trinity College Dublin, Ireland)
  • John Strang (Professor, Head of the Addictions Department, Institute of Psychiatry, Psychology & Neuroscience (IoPPN), King’s College London, UK)
  • Jørgen G. Bramness (Senior researcher, Norwegian National Advisory Unit on Concurrent Substance Abuse and Mental Health Disorders, Norwegian Centre of Dual Diagnosis, Norway)
  • Julian Vicente (MD, MPH, EMCDDA former Lead scientist, epidemiology, Lisbon, Portugal)
  • Jürgen Rehm (Director, Social and Epidemiological Research (SER) Department, Centre for Addiction and Mental Health, Toronto, Canada)
  • Katrin Schiffer (Coordinator CORRELATION network)
  • Kim Moeller (Associate Professor, Faculty of Health and Society, Department of criminology, Malmö University, Sweden)
  • Krzysztof Krajewski (Chair of Criminology, Jagiellonian University, Poland)
  • Laura Amato (Director unit of research synthesis del S.S.R.- ASL Roma1 Regione Lazio, Italy)
  • Laura Ferrer-Wreder (Department of Psychology, Stockholm University, Sweden)
  • Letizia Paoli (Professor, Leuven Institute of Criminology, University of Leuven, Faculty of Law, Belgium)
  • Lidia Segura Garcia (Department of Clinical and Health Psychology, Universitat Autònoma de Barcelona, Spain)
  • Louisa Degenhardt (Professor, National Drug and Alcohol Research Centre (NDARC), Australia)
  • Ludwig Kraus (Director, IFT Institut für Therapieforschung, Munich, Germany)
  • Manuela Grazina (Professor, Faculty of Medicine; Researcher and Head of Laboratory of Biochemical Genetics, Center for Neuroscience and Cell Biology; University of Coimbra, Portugal)
  • Marc Potenza (Albert E Kent Professor of Psychiatry and Professor in the Child Study Center and of Neuroscience; Director, Center of Excellence in Gambling Research; Director, Yale Program for Research on Impulsivity and Impulse Control Disorders; Director, Women and Addictive Disorders, Women's Health Research at Yale, USA)
  • Marcin Wojnar (Professor of Psychiatry and the Chair of the Department of Psychiatry, Medical University of Warsaw, Poland)
  • Margarida Gaspar de Matos (Faculdade de Motricidade Humana and Instituto de Saúde Ambiental/Faculdade de Medicina, University of Lisbon, Portugal)
  • Margriet Van Laar (Head of the Department Drug Monitoring, Trimbos Institute, Netherlands)
  • Marie Jauffret-Roustide (Researcher at the French National Institute of Health and Medical Research (Inserm), Centre for the Study of Social Movements (CEMS), EHESS, Paris, France)
  • Marieke Liem (Professor Security and Interventions, Leiden University, The Hague, Netherlands)
  • Marta Torrens Mèlich (Director of the Addiction at Neuropsychiatric and Addictions at Hospital del Mar , Barcelona and Professor of Psychiatry at Universitat Autònoma de Barcelona and UVic-UCC, Spain)
  • Matthew Hickman (School of Social and Community Medicine, University of Bristol, UK)
  • Mayyada Wazaify (Professor of Pharmacy Practice, School of Pharmacy, The University of Jordan, Amman, Jordan Docent in Social Pharmacy, University of Helsinki, Finland)
  • Meni Malliori (Professor of Psychiatry, Eginition Hospital, National & Kapodistrian University of Athens, Greece)
  • Michael Farrell (Director, National Drug and Alcohol Research Centre (NDARC), University of New South Wales, Australia)
  • Nicola Singleton (Visiting Researcher, National Addictions Centre, King’s College, London, UK)
  • Ornella Corazza (Reader in Substance Addictions and Behaviours, University of Hertfordshire, Hatfield, UK)
  • Pam Kent (Director, Research and Emerging Trends, Canadian Centre on Substance Use and Addiction, Canada)
  • Paul Dargan (Consultant Physician and Clinical Toxicologist, Guy's and St Thomas' NHS Foundation Trust, and Reader in Toxicology, King’s College London, UK)
  • Paul Dietze (Co-Director, Disease Elimination Program, Burnet Institute and Professor, National Drug Research Institute, Curtin University, Perth, Australia)
  • Peter Adams (Associate Director, Centre for Addiction Research, School of Population Health, University of Auckland, New Zealand)
  • Pia Mäkelä (Research Professor, Finnish Institute for Health and Welfare, Finland)
  • Rachel Btaiche (Focal Person, National Observatory on Drugs and Drug Addiction, Ministry of Public Health, Lebanon)
  • Rainer Spanagel (Professor of Pharmacology & Toxicology, Head of the Institute of Psychopharmacology, University of Heidelberg, Germany)
  • Rebecca McKetin (Associated professor, National Drug and Alcohol Research Centre, University of New South Wales, Australia)
  • Ricardo Gonçalves (Centro de Estudos em Gestão e Economia, Universidade Católica do Porto, Portugal)
  • Samuel Tomczyk (Institute of Psychology, Department Health and Prevention, University of Greifswald, Germany)
  • Susana Jiménez-Murcia (Head of Pathological Gambling Unit, Department of Psychiatry, University Hospital of Bellvitge, Barcelona, Spain)
  • Teresa Summavielle (Head of the Addiction Biology Group at i3S, Instituto de Investigação e Inovação em Saúde da Universidade do Porto, Portugal)
  • Thomas Clausen (Norwegian Centre for Addiction Research (SERAF), Institute of Clinical Medicine, University of Oslo, Norway)
  • Tim Rhodes (Professor of Public Health Sociology, London School of Hygiene and Tropical Medicine, UK / University of New South Wales, Australia)
  • Tomi Lintonen (Research director of the Finnish Foundation for Alcohol Studies, Finland)
  • Torsten Kolind (Director, Centre for Alcohol and Drug Research, Aarhus University, Denmark)
  • Virginia Berridge (Professor of History and Director, Centre for History in Public Health, London School of Hygiene and Tropical Medicine, UK)
  • William Crano (Claremont Graduate University's Division of Behavioral & Organizational Sciences, USA)
  • Zili Sloboda (President, Applied Prevention Science, Inc., USA)
  • Zsolt Demetrovics (ELTE Eötvös Loránd University, Budapest, Hungary)

Categories:

  • Committee